These Small Cap Stocks Are Getting Major Attention Today

NEW YORK, NY / ACCESSWIRE / February 26, 2016 / The Stock Expert is issuing a report on four stocks that are trading with heavier than usual volume. RJET, GLBL, CARA and MNKD are on high volume alert. Continue reading to find out why these stocks are getting so much interest today. – To get daily alerts on the hottest stocks on the Nasdaq/NYSE subscribe to our newsletter at TheStockExpert.com.

Republic Airways Holdings Inc. (Nasdaq: RJET) Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. The company offers scheduled passenger service on approximately 1,229 flights daily to approximately 101 cities in the U.S. and Canada. Shares of Republic Airways are trading lower today by 72% after the company filed for Chapter 11 bankruptcy after struggling with labor issues. The announcement came after Thursday’s market close and the stock dropped 75% pre market today. As Donald Trump has stated, filing for bankruptcy can be a shrewd business decision and the Republic Airways Board of Directors agrees. The Board believes that this strategy is in the best interests of the company and its shareholders.

Get Your Free Membership Now.

TerraForm Global, Inc. (Nasdaq: GLBL) TerraForm Global, Inc. owns and operates renewable energy generation assets worldwide. It generates electricity through solar, wind, and hydro-electric projects with a total combined capacity of 987.8 megawatts. Shares of TerraForm bounced off its 52 week low nicely yesterday and has been in oversold territory for the last few trading days. The stock is trading higher by 14% on the day off heavier than usual volume. The rise in share price should only be temporary and as of just two days ago, Moody’s downgraded TerraForm and the company has a negative outlook.

Like What You See? Get These Alerts and Many More on NASDAQ Companies before They Rally, Find Out More Here.

Cara Therapeutics Inc. (Nasdaq: CARA) Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. Shares of Cara Therapeutics are trading lower today off by 35% and is trading at its 52 week low after the FDA placed their pain trail on clinical hold. I.V. CR845 has been placed on clinical hold pending a pre-specific safety review. The stock reacted very negatively to the news, however, the Company did note that no serious adverse events have been reported with CR845. The hold could inevitably delay the release of their blockbuster drug, lengthening the timetable for FDA approval.

Get the Information You Need To Stay Informed and Up To Date On The Hottest NASDAQ Plays Get Them Here.

MannKind Corp. (Nasdaq: MNKD) MannKind Corporation, a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes is trading lower today off heavier than usual volume. The Company is dealing with several serious issues at the moment. First, Mannkind is anticipating that it will be unable to timely file its Annual Report on Form 10-K for the year ended December 31, 2015 by filing deadline, February 29, and second, their Chairman, Emeritus Alfred E. Mann has passed away at the age of 90. The company is mourning their loss today as short interest rises in the biotech sector.

NASDAQ Stock Alerts: Check Them Out Here To Receive Our Winning NASDAQ & NYSE Stock Alerts For Free.

About TheStockExpert.com

The Stock Expert is a newsletter alert service that focuses on companies on the NASDAQ & NYSE. We only highlight quality companies with big news on high volume days. This commitment provides our subscribers with only the best recommendations of companies for short and long-term investments.

To receive free text message alerts on your phone, compose a new text message to the number 95577 with the word “STOCKEXPERT”.

Disclosure: The information, opinions and analysis contained in this report are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We do not accept any responsibility or liability for any losses, damages or costs arising from an investor’s or other person’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities, nor a recommendation of any security. Past gains are not representative of future gains. The Stock Expert has not been compensated nor does it expect to receive any compensation for distribution of its opinions and publicly available information regarding the companies reported in this investment opinion article at this time. The opinions contained herein contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. When used herein, the words “anticipate,” “intend,” “estimate,” “believe,” “expect,” “plans,” “should,” “potential,” “forecast,” and variations of such words and similar expressions are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A company’s actual results could differ materially from those described in any forward-looking statements contained herein. The Stock Expert is not a licensed broker, broker dealer, market maker, investment advisor, analyst or underwriter. We recommend that you use the information found herein as an initial starting point for conducting your own research in order to determine your own personal opinion of the companies discussed herein before deciding whether or not to invest. You should seek such investment, tax, financial, accounting or legal advice appropriate for your particular circumstances. Information about many publicly traded companies and other investor resources can be found at www.sec.gov. Investing in securities is speculative and carries risk. Please visit TheStockExpert.com/disclaimer website for a more detailed discussion of risks and disclosures.

Contact:

Justin Skibinski
The Stock Expert
info@thestockexpert.com

SOURCE: The Stock Expert

ReleaseID: 437242